###begin article-title 0
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity
###end article-title 0
###begin p 1
###xml 32 54 32 54 <email xmlns:xlink="http://www.w3.org/1999/xlink">hwatarai@rcai.riken.jp</email>
CORRESPONDENCE Hiroshi Watarai: hwatarai@rcai.riken.jp
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 459 460 459 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 533 534 533 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 538 539 538 539 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 642 643 642 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 705 706 705 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 789 792 785 788 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 861 862 857 858 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 878 879 874 875 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 903 906 895 898 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1002 1003 994 995 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1007 1008 999 1000 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 793 797 <span type="species:ncbi:10090">mice</span>
###xml 907 911 <span type="species:ncbi:10090">mice</span>
Airway hypersensitive reaction (AHR) is an animal model for asthma, which is caused or enhanced by environmental factors such as allergen exposure. However, the precise mechanisms that drive AHR remain unclear. We identified a novel subset of natural killer T (NKT) cells that expresses the interleukin 17 receptor B (IL-17RB) for IL-25 (also known as IL-17E) and is essential for the induction of AHR. IL-17RB is preferentially expressed on a fraction of CD4+ NKT cells but not on other splenic leukocyte populations tested. IL-17RB+ CD4+ NKT cells produce predominantly IL-13 and Th2 chemokines upon stimulation with IL-25 in vitro. IL-17RB+ NKT cells were detected in the lung, and depletion of IL-17RB+ NKT cells by IL-17RB-specific monoclonal antibodies or NKT cell-deficient Jalpha18-/- mice failed to develop IL-25-dependent AHR. Cell transfer of IL-17RB+ but not IL-17RB- NKT cells into Jalpha18-/- mice also successfully reconstituted AHR induction. These results strongly suggest that IL-17RB+ CD4+ NKT cells play a crucial role in the pathogenesis of asthma.
###end p 3
###begin p 4
A. Terashima and H. Watarai contributed equally to this paper.
###end p 4
###begin p 5
###xml 38 39 38 39 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 149 150 149 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 234 235 234 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 483 484 483 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
Airway hypersensitive reaction (AHR) (1) is known to be associated with Th2 cytokines-including IL-4, IL-5, and IL-13-regulating effector functions (2). Indeed, overexpression of these Th2 cytokines results in the development of AHR (3). However, efforts to ameliorate experimental asthma with antibodies against Th2 cytokines have generally proven unsuccessful. Among these, only IL-13 seems to be a key cytokine responsible for goblet cell hyperplasia, airway remodeling, and AHR (4), because inhibition of IL-13 activity, but not that of other Th2 cytokines, by a blocking antibody suppresses both AHR and airway inflammation.
###end p 5
###begin p 6
###xml 90 91 90 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 92 93 92 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 162 163 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 181 182 181 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 218 219 218 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 279 281 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 387 388 387 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 451 452 451 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 772 773 772 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 775 777 775 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 302 306 <span type="species:ncbi:10090">mice</span>
###xml 380 385 <span type="species:ncbi:9606">human</span>
###xml 393 398 <span type="species:ncbi:10090">mouse</span>
IL-25 (also known as IL-17E), a member of the structurally related IL-17 cytokine family (5-7), has recently been reported to be produced by activated Th2 cells (5) and mast cells (8), resulting in enhancement of AHR (9, 10). Administration of a blocking antibody against IL-25 (11) or IL-25-deficient mice (12) eliminates Th2 responses. Conversely, systemic expression of either human (7) or mouse (11) IL-25, or administration of recombinant IL-25 (5), induces Th2-type immune responses, including increased serum IgE levels, blood eosinophilia, and pathological changes in the lung and other tissues. These findings clearly demonstrate a pivotal role of IL-25 as a mediator of Th2 responses, suggesting that IL-25 lies upstream of the classical Th2 cytokine responses (5, 11).
###end p 6
###begin p 7
###xml 86 102 86 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V&#945;14J&#945;18</italic>
###xml 114 130 106 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V&#945;24J&#945;18</italic>
###xml 224 227 204 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 270 272 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 414 415 394 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 427 439 407 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MHC class II</italic>
###xml 456 458 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 134 140 <span type="species:ncbi:9606">humans</span>
###xml 228 232 <span type="species:ncbi:10090">mice</span>
###xml 450 454 <span type="species:ncbi:10090">mice</span>
###xml 685 690 <span type="species:ncbi:10090">mouse</span>
###xml 787 792 <span type="species:ncbi:10090">mouse</span>
NKT cells characterized by the expression of an invariant antigen receptor encoded by Valpha14Jalpha18 in mice or Valpha24Jalpha18 in humans are also involved in the development of asthma, because NKT cell-deficient Jalpha18-/- mice fail to develop antigen-induced AHR (13). Th2 cells are not always essential for NKT cell-mediated AHR development, because activation of NKT cells induces AHR in the absence of CD4+ T cells in MHC class II-deficient mice (14). These findings suggest that NKT cells are directly involved in the development of AHR independent of Th2 responses in some conditions. In this report, we investigated the role of IL-25 in NKT cell-dependent AHR induction in mouse models and found that IL-17RB, a receptor for IL-25, was selectively expressed on a fraction of mouse NKT cells, which preferentially produced IL-13 and induced the development of AHR upon stimulation with IL-25.
###end p 7
###begin title 8
RESULTS AND DISCUSSION
###end title 8
###begin p 9
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 163 164 163 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 434 435 434 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 596 597 596 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 750 751 750 751 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 764 765 758 759 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 894 896 888 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 942 943 936 937 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 982 983 976 977 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 996 997 984 985 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1016 1017 996 997 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1174 1175 1146 1147 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1235 1236 1207 1208 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1247 1248 1219 1220 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1261 1262 1233 1234 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1282 1283 1246 1247 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1297 1298 1261 1262 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1313 1314 1277 1278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1323 1324 1287 1288 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1376 1384 1340 1348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 421 426 <span type="species:ncbi:10090">mouse</span>
###xml 621 626 <span type="species:ncbi:10090">mouse</span>
We first investigated the role of IL-25 in the development of AHR in relation to NKT cells because of previous findings that IL-25 induces Th2-biased responses (5-7). The receptor for IL-25, termed IL-17RB or EVI27/IL-17BR, was originally found to bind IL-17B (15). Interestingly, however, the receptor binds IL-25 with higher affinity than IL-17B. Therefore, this receptor is now termed IL-17RB/IL-25R (15). To identify mouse IL-17RB+ cells, we generated specific mAbs (Fig. S1, available at ) by immunization with a recombinant IL-17RB-Ig fusion protein (Fig. S2). We first investigated IL-17RB+ cells in the spleen by mouse IL-17RB mAb to confirm the previous findings that IL-17RB expression is detected on a fraction of non-B/non-T (NBNT), c-kit+, FcepsilonRI- cells in the mesenteric lymph node (Fig. S3), which has identified as IL-4-, IL-5-, IL-13-producing cells in response to IL-25 (12). NKT cells were distinct from the NBNT c-kit+ cells based on the expression of c-kit-, FcepsilonRI-, Valpha14-Jalpha18+ transcripts detected by RT-PCR (Fig. S4). Moreover, IL-17RB was preferentially expressed on a fraction of alpha-galactosylceramide (alpha-GalCer)/CD1d dimer+ NKT cells but not on other cell types, including NBNT c-kit+ cells, CD4+ T cells, CD8+ T cells, gammadelta+ T cells, CD19+ B cells, CD11c+ DCs, DX5+ NK cells, or noninvariant NKT cells in the spleen (Fig. 1 A).
###end p 9
###begin p 10
###xml 58 59 58 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 0 70 0 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Phenotypic and gene expression profiles of splenic IL-17RB<sup>+</sup> NKT cells.</bold>
###xml 100 101 100 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 196 197 196 197 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 320 321 320 321 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 359 360 359 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 447 448 447 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 452 453 452 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 466 467 466 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 471 472 471 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 840 841 840 841 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 845 846 845 846 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 871 872 871 872 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 876 877 876 877 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
###xml 310 313 <span type="species:ncbi:10116">rat</span>
Phenotypic and gene expression profiles of splenic IL-17RB+ NKT cells. (A) Identification of IL-17RB+ cells from BALB/c mice. The indicated populations were gated and analyzed by FACS using F(ab')2 fragments of the anti-IL-17RB mAb B5F6. Shaded profiles in the histograms indicate the background staining with rat F(ab')2 IgG2a. (B) FACS profile of CD1d dimer+ NKT cells stained with anti-CD4 and anti-IL-17RB. (C) Surface phenotype of DN, IL-17RB- CD4+, and IL-17RB+ CD4+ NKT cells indicated in B. Shaded profiles in the histograms indicate the background staining with isotype-matched control antibody. Percentages are shown. (D-H) Quantitative analyses of genes for chemokine receptors (D), Th1-related molecules (E), Th2-related molecules (F), cytotoxic molecules (G), and Th17-related molecules (H) in isolated DN (black bars), IL-17RB- CD4+ (gray bars), and IL-17RB+ CD4+ (white bars) NKT cells. Expression of each mRNA was determined by quantitative real-time PCR using the primer sets shown in Table S1 (available at ) and is depicted as the number of transcripts per one copy of the housekeeping gene HPRT. One representative out of three experiments is shown (means +/- SEM).
###end p 10
###begin p 11
###xml 265 266 265 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 276 277 276 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 280 281 280 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 315 317 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 376 377 376 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 487 488 487 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 492 493 492 493 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 506 507 506 507 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 511 512 511 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 524 532 524 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 568 569 568 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 669 670 669 670 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 674 675 674 675 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 687 695 687 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 738 739 738 739 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 788 789 788 789 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 793 794 793 794 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 920 921 920 921 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 950 951 950 951 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 955 956 955 956 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1116 1118 1116 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
The preferential expression of IL-17RB in a fraction of NKT cells raises a question about the phenotypic and functional characteristics of these cells. Based on our current understanding, NKT cells are divided into two populations based on CD4/CD8 expression: a CD4+ and a CD4-CD8- double-negative (DN) population (16). Using an IL-17RB mAb, we found that one third of the CD4+ but none of the DN NKT cells expressed IL-17RB, indicating the existence of three subpopulations: DN, IL-17RB- CD4+, and IL-17RB+ CD4+ NKT cells (Fig. 1 B). Moreover, the majority of IL-17RB+ NKT cells were dimly positive for CD69 and CD122 compared with brightly positive DN NKT and IL-17RB- CD4+ NKT cells (Fig. 1 C). The expression level of CD62L by IL-17RB+ NKT cells was low, comparable to that on IL-17RB- CD4+ NKT cells and similar to that of conventional memory T cells, whereas it was quite high on DN NKT cells. In addition, IL-17RB+ NKT cells (3%), like IL-17RB- CD4+ NKT cells (11%), barely expressed an NK receptor, NKG2D, which was highly expressed on the majority (>60%) of DN NKT cells, suggesting their cytotoxic nature (17).
###end p 11
###begin p 12
###xml 73 74 73 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 227 231 227 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCR4</italic>
###xml 267 268 267 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 355 360 355 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CXCR6</italic>
###xml 373 381 373 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 D</xref>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 560 562 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
To investigate cytokine and chemokine gene expression profiles on IL-17RB+ NKT cells, we performed quantitative real-time PCR using primer sets as shown in Table S1 (available at ). The expression of the Th2 chemokine receptor CCR4 was several times higher on IL-17RB+ NKT cells than on the other subsets, whereas no significant differences were found in CXCR6 expression (Fig. 1 D), which is important for NKT cell migration (18). The results are consistent with the previous findings that NKT cells require CCR4 to localize to the airways and to induce AHR (19).
###end p 12
###begin p 13
###xml 41 42 41 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 186 188 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 212 213 208 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 283 292 279 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFN-&#947;</italic>
###xml 294 299 286 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T-bet</italic>
###xml 301 306 293 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stat4</italic>
###xml 308 318 300 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-18R&#946;</italic>
###xml 324 335 313 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-12R&#946;2</italic>
###xml 337 345 323 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 E</xref>
###xml 400 404 386 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-4</italic>
###xml 420 428 406 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 F</xref>
###xml 498 506 484 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Granzyme</italic>
###xml 508 516 494 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perforin</italic>
###xml 522 538 508 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">killer receptors</italic>
###xml 540 545 526 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KIRa1</italic>
###xml 547 552 533 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KIRc1</italic>
###xml 554 559 540 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KIRd1</italic>
###xml 565 571 551 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KIRg1)</italic>
###xml 612 620 598 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 G</xref>
###xml 679 680 665 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 733 735 719 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 814 822 800 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 849 855 835 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-17A</italic>
###xml 860 869 846 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ROR&#947;t</italic>
###xml 892 893 874 875 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 974 982 956 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 H</xref>
###xml 1079 1080 1061 1062 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Concerning cytokine production of IL-17RB+ NKT cells, it is reported that NKT cells produce both Th1 and Th2 cytokines at the same time upon stimulation with their ligand, alpha-GalCer (20). Surprisingly, IL-17RB+ NKT cells expressed lower levels of Th1-related transcripts, such as IFN-gamma, T-bet, Stat4, IL-18Rbeta, and IL-12Rbeta2 (Fig. 1 E), whereas higher levels of the Th2-related transcript IL-4 were detected (Fig. 1 F). In contrast, transcripts for cytotoxic effector molecules, such as Granzyme, Perforin, and killer receptors (KIRa1, KIRc1, KIRd1, and KIRg1), were expressed mainly in DN NKT cells (Fig. 1 G), supporting the previous findings that DN NKT but not CD4+ NKT cells predominantly mediate antitumor immunity (19) and also that NKG2D was predominantly expressed on DN NKT cells, as shown in Fig. 1 C. The expression levels of IL-17A and RORgammat transcripts in IL-17RB+ NKT cells, which are high in Th17 cells, were lower than those in DN NKT cells (Fig. 1 H). These results on surface phenotypes and mRNA expression profiles clearly indicate that IL-17RB+ NKT cells are Th2-type NKT cells and are distinct from other NKT cells, such as DN NKT cells or IL-17-producing NKT cells.
###end p 13
###begin p 14
###xml 41 42 41 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 91 92 91 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 108 109 108 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 117 118 117 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 212 220 212 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 353 355 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 383 385 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 459 460 455 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 563 571 555 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 591 592 583 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 813 821 805 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 874 875 866 867 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Next, we analyzed the function of IL-17RB+ NKT cells in response to IL-25 in vitro. IL-17RB+ NKT but not CD4+ IL-17RB- nor DN NKT cells responded to IL-25 in a dose-dependent manner only in the presence of APCs (Fig. 2 A), which is similar to previous findings on the requirement of two signals, such as IL-12 and CD1d on APCs for IFN-gamma production (21) and for IL-21 production (22), in NKT cell activation. Under these conditions, IL-25-activated IL-17RB+ NKT cells mainly produced IL-13, along with modest production of IL-4, but barely produced IFN-gamma (Fig. 2 B). Moreover, IL-17RB+ NKT cells produced Th2 chemokines such as thymus and activation-regulated chemokine/CCL17, macrophage-derived chemokine/CCL22, and C10/CCL6 as well as eosinophil chemotactic factor-L (ECF-L) upon stimulation with IL-25 (Fig. 2 C). These results indicate that IL-25 triggers IL-17RB+ NKT cells to preferentially produce the IL-13, Th2 chemokines, and ECF-L important for recruitment of eosinophils.
###end p 14
###begin p 15
###xml 29 30 29 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 34 35 34 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 0 46 0 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Properties of splenic IL-17RB<sup>+</sup> CD4<sup>+</sup> NKT cells.</bold>
###xml 117 118 117 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 122 123 122 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 136 137 136 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 141 142 141 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 191 192 191 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 257 258 257 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 266 267 266 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 370 371 370 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 616 617 614 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 621 622 619 620 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 641 642 639 640 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 646 647 644 645 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 661 662 659 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 708 709 706 707 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 717 718 715 716 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 780 781 778 779 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 785 786 783 784 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Properties of splenic IL-17RB+ CD4+ NKT cells. (A and B) Proliferation (A) and cytokine production (B) of DN, IL-17RB- CD4+, and IL-17RB+ CD4+ NKT cells. Indicated NKT cell subpopulations (106 cells/ml) were co-cultured for 3 d with or without splenic CD11c+ DCs (105 cells/ml) in the absence or presence of IL-25 (0, 1, and 10 ng/ml), and proliferation was assayed by [3H]thymidine incorporation (A) or cytokine production by cytokine bead array (B). The data are shown as the means +/- SD of three cultures. The data are representative of four independent experiments. (C) Quantitative analysis of genes in IL-17RB+ CD4+ NKT cells. IL-17RB+ CD4+ NKT cells (106 cells/ml) were co-cultured with splenic CD11c+ DCs (105 cells/ml) in the presence of 10 ng/ml IL-25 for 48 h. IL-17RB+ CD4+ NKT cells were sorted and analyzed for their gene expression by quantitative real-time PCR, as described in Materials and methods. The data are representative of three independent experiments (means +/- SEM).
###end p 15
###begin p 16
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 173 179 173 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-17A</italic>
###xml 195 196 195 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 258 266 258 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 288 294 288 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-17A</italic>
###xml 299 308 299 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ROR&#947;t</italic>
###xml 324 325 320 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 375 383 371 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 H</xref>
###xml 413 422 409 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ROR&#947;t</italic>
###xml 479 488 471 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ROR&#947;t</italic>
###xml 499 500 487 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 512 520 500 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 H</xref>
###xml 544 545 532 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 700 702 688 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 704 706 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 818 820 806 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 949 951 937 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 988 989 976 977 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 694 698 <span type="species:ncbi:10090">mice</span>
Recently, other IL-17 family members, IL-17A or IL-17F, have been shown to be involved in chronic inflammatory and allergic lung diseases (23, 24). The expression levels of IL-17A mRNA in IL-17RB+ NKT cells were slightly elevated after treatment with IL-25 (Fig. 2 C). However, levels of IL-17A and RORgammat mRNA in IL-17RB+ NKT cells were lower than those in DN NKT cells (Fig. 1 H). Because high expression of RORgammat is one of the markers for Th17 cells, low expression of RORgammat in IL-17RB+ NKT cells (Fig. 1 H) indicates that IL-17RB+ NKT cells are distinct from IL-17-producing NKT cells. In addition, even though NK1.1-negative NKT cells represent IL-17-producing cells in C57BL/6 mice (25, 26), it has also been reported that IL-17-producing NKT cells are not restricted to a particular NKT cell subset (27). Another report has also revealed that ozone- but not allergen-induced AHR requires IL-17A produced from both NKT and T cells (28). These results suggest that IL-17RB+ NKT cells described in this report are not equivalent to IL-17A-producing NKT cells reported by others.
###end p 16
###begin p 17
###xml 52 53 52 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 162 163 162 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 349 350 349 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 565 566 565 566 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 641 649 641 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 694 702 694 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 808 809 808 809 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 823 824 815 816 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 833 834 825 826 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 916 924 908 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 78 83 <span type="species:ncbi:10090">mouse</span>
###xml 227 231 <span type="species:ncbi:10090">mice</span>
###xml 292 296 <span type="species:ncbi:10090">mice</span>
We further examined whether the frequency of IL-17RB+ NKT cells differs among mouse strains because allergic responses are strain dependent. Intriguingly, IL-17RB+ NKT cells were fairly abundant in Th2-prone BALB/c and DBA2/cr mice but were barely detectable in Th1-prone C57BL/6 and C3H/HeN mice (Fig. S5, available at ). We also found that IL-17RB+ NKT cells were detected more in the lung and spleen than the thymus but were almost undetectable in the liver. Although the number of NKT cells in the lung was one tenth of that in the spleen or the thymus, IL-17RB+ NKT cells make up a higher proportion in the total NKT cells in the lung (Fig. 3 A). Similar to the splenic NKT cells shown in Fig. 1 A, the selective expression of IL-17RB on NKT cells was also detected in the lung, whereas conventional CD4+ T, gammadelta+ T, c-kit+ NBNT, and noninvariant NKT cells in the lung were negative or barely detectable (Fig. 3 B).
###end p 17
###begin p 18
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 0 74 0 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Involvement of IL-17RB<sup>+</sup> NKT cells in the development of IL-25&#8211;induced AHR.</bold>
###xml 115 116 115 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 237 238 233 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 392 393 388 389 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 489 490 485 486 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 498 499 494 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 569 570 565 566 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 1206 1209 1196 1199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1693 1696 1677 1680 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1743 1746 1723 1726 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1770 1771 1750 1751 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 338 342 <span type="species:ncbi:10090">mice</span>
###xml 479 482 <span type="species:ncbi:10116">rat</span>
###xml 759 763 <span type="species:ncbi:10090">mice</span>
###xml 914 918 <span type="species:ncbi:10090">mice</span>
###xml 1087 1091 <span type="species:ncbi:10090">mice</span>
###xml 1210 1214 <span type="species:ncbi:10090">mice</span>
###xml 1418 1422 <span type="species:ncbi:10090">mice</span>
###xml 1523 1527 <span type="species:ncbi:10090">mice</span>
###xml 1701 1705 <span type="species:ncbi:10090">mice</span>
###xml 1751 1755 <span type="species:ncbi:10090">mice</span>
Involvement of IL-17RB+ NKT cells in the development of IL-25-induced AHR. (A and B) Tissue distribution of IL-17RB+ NKT cells (A) and IL-17RB expression among lung mononuclear cell populations (B) in BALB/c mice. alpha-GalCer/CD1d dimer+ NKT cells in the indicated organs (A) and mononuclear cell populations in the lung (B) from BALB/c mice were gated and analyzed by FACS using B5F6 F(ab')2 IL-17RB mAb. Shaded profiles in the histograms indicate the background staining with rat F(ab')2 IgG2a (n = 3). Percentages are shown. (C) Development of AHR. The changes in RL were measured. The detailed method for development of OVA/IL-25-induced AHR is described in Materials and methods. Results are expressed as the mean +/- SEM. The group of IL-25-treated WT mice was compared with three other groups. *, P < 0.05; and **, P < 0.01 calculated by ANOVA. The results represent one out of three experiments with five mice in each group. (D and G) Total and differential cell counts (D) and cytokines (G) in BAL fluid. BAL fluid was collected 24 h after challenge with intranasal OVA of the mice depicted in C. IL-25-induced pulmonary inflammation (D) and IL-13 and IL-5 production (G) were reduced in Jalpha18-/- mice. The data on cytokines in G are expressed as the amounts detected in the 10-fold PBS-diluted BAL samples. Results are expressed as means +/- SEM. *, P < 0.05; **, P < 0.01. The group of IL-25-treated WT mice was compared with three other groups. These results represent one out of four experiments with five mice in each group. (E and F) Histological analysis of lung tissues with hematoxylin and eosin (E) and periodic acid Schiff (F) staining. IL-25-treated WT (c) or Jalpha18-/- (d) mice were compared with WT (a) or Jalpha18-/- (b) mice from control (n = 4). Bars,100 mum.
###end p 18
###begin p 19
###xml 28 29 28 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 406 414 406 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 490 493 486 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 591 599 587 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 626 629 618 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 762 770 754 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 D</xref>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
###xml 328 332 <span type="species:ncbi:10090">mice</span>
###xml 494 498 <span type="species:ncbi:10090">mice</span>
###xml 585 589 <span type="species:ncbi:10090">mice</span>
###xml 612 616 <span type="species:ncbi:10090">mice</span>
###xml 630 634 <span type="species:ncbi:10090">mice</span>
To determine whether IL-17RB+ NKT cells are required for IL-25 in the development of AHR, WT mice were immunized with a suboptimal dose of OVA/alum twice and were subsequently treated with PBS before a single intranasal OVA challenge (see Materials and methods). Under these conditions, the mice failed to develop AHR. When the mice were subsequently treated with IL-25 instead of PBS, they developed AHR (Fig. 3 C). In contrast, even after treatment with IL-25, NKT cell-deficient Jalpha18-/- mice failed to develop significant AHR, comparable to that seen in the PBS-treated control mice (Fig. 3 C). Unlike WT mice, Jalpha18-/- mice treated with IL-25 significantly reduced numbers of airway macrophages, eosinophils, neutrophils, and lymphocytes in the lung (Fig. 3 D).
###end p 19
###begin p 20
###xml 267 270 263 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 351 354 343 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 361 369 353 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 E</xref>
###xml 483 486 471 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 493 501 481 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 F</xref>
###xml 580 581 568 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 699 700 683 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">/</italic>
###xml 698 701 682 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;<italic>/</italic>&#8722;</sup>
###xml 890 898 874 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 G</xref>
###xml 920 921 904 905 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 977 985 961 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 1009 1017 993 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
###xml 271 275 <span type="species:ncbi:10090">mice</span>
###xml 355 359 <span type="species:ncbi:10090">mice</span>
###xml 487 491 <span type="species:ncbi:10090">mice</span>
###xml 702 706 <span type="species:ncbi:10090">mice</span>
###xml 884 888 <span type="species:ncbi:10090">mice</span>
Hematoxylin and eosin staining of the lung tissue of IL-25-treated WT mice revealed that the levels of infiltration of inflammatory mononuclear cells into the peribronchiolar region were higher in WT mice with severe tissue destruction compared with those in Jalpha18-/- mice. No inflammatory cell infiltration was detected in untreated WT or Jalpha18-/- mice (Fig. 3 E). By periodic acid Schiff staining, mucus-producing cells were abundant only in IL-25-treated WT but not Jalpha18-/- mice (Fig. 3 F). To further investigate the effects on allergic responses mediated by IL-17RB+ NKT cells, we examined cytokine production in the bronchoalveolar lavage (BAL) fluid of IL-25-treated WT or Jalpha18-/- mice and controls. The production of IL-5 and IL-13, which plays a crucial role in the recruitment of eosinophils and Th2 cells, respectively, were detected only in IL-25-treated WT mice (Fig. 3 G). Even though IL-17RB+ NKT cells did not produce IL-5 upon IL-25 stimulation (Fig. 2 B), they produced ECF-L (Fig. 2 C), which is important for the recruitment of eosinophils producing IL-5. These results strongly suggest that IL-25 acts directly on NKT cells and induces AHR.
###end p 20
###begin p 21
###xml 36 37 36 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 127 128 127 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 212 213 212 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 252 254 248 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 262 264 255 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 337 338 323 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 386 387 372 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 399 407 385 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 417 418 403 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 493 501 479 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 569 570 555 556 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 584 585 562 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 603 604 581 582 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 721 729 699 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 C</xref>
###xml 804 805 782 783 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 817 825 795 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 899 907 877 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 C</xref>
###xml 935 936 913 914 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 967 975 945 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
We then investigated whether IL-17RB+ NKT cells are involved in the development of IL-25-dependent AHR, and we depleted IL-17RB+ cells with 3H8 IL-17RB mAb. Among the NKT cell populations, the majority of IL-17RB+ NKT cells were alpha-GalCer/CD1d dimerhi TCRbetahi, indicating that the expression level of TCRalpha and TCRbeta on IL-17RB+ NKT cells was higher than that on other IL-17RB- NKT cells (Fig. 4 A). IL-17RB+ NKT depletion persisted for at least 5 d after 3H8 IL-17RB mAb injection (Fig. 4 B), whereas no effects were detected on other cell types, such as CD4+ T, gammadelta+ T, and NBNT c-kit+ cells (Fig. S6, available at ). As expected, treatment of 3H8 IL-17RB mAb significantly induced suppression of AHR (Fig. 4 C), which was tightly correlated with the reduction of the number of IL-17RB+ NKT cells (Fig. 4 B). Administration of an isotype-matched control mAb did not suppress AHR (Fig. 4 C), and the number of IL-17RB+ NKT cells remained unchanged (Fig. 4 B).
###end p 21
###begin p 22
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 0 74 0 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Requirement of IL-17RB<sup>+</sup> NKT cells in the development of IL-25&#8211;induced AHR.</bold>
###xml 159 161 155 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 169 171 162 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 209 212 198 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 220 223 206 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 325 326 311 312 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 408 410 390 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 418 420 397 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 432 433 411 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 528 529 503 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 537 538 509 510 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 724 725 696 697 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 832 834 800 802 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 842 844 807 809 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 861 862 826 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1232 1233 1196 1197 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 1567 1568 1529 1530 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1592 1595 1550 1553 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1742 1743 1700 1701 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1752 1753 1710 1711 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1869 1872 1823 1826 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1963 1964 1916 1917 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 2011 2012 1964 1965 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 260 264 <span type="species:ncbi:10090">mice</span>
###xml 474 478 <span type="species:ncbi:10090">mice</span>
###xml 575 579 <span type="species:ncbi:10090">mice</span>
###xml 648 651 <span type="species:ncbi:10116">rat</span>
###xml 664 669 <span type="species:ncbi:10090">mouse</span>
###xml 918 922 <span type="species:ncbi:10090">mice</span>
###xml 1079 1083 <span type="species:ncbi:10090">mice</span>
###xml 1122 1125 <span type="species:ncbi:10116">rat</span>
###xml 1138 1143 <span type="species:ncbi:10090">mouse</span>
###xml 1274 1277 <span type="species:ncbi:10116">rat</span>
###xml 1295 1299 <span type="species:ncbi:10090">mice</span>
###xml 1439 1443 <span type="species:ncbi:10090">mice</span>
###xml 1596 1600 <span type="species:ncbi:10090">mice</span>
###xml 1873 1877 <span type="species:ncbi:10090">mice</span>
###xml 2034 2038 <span type="species:ncbi:10090">mice</span>
###xml 2206 2210 <span type="species:ncbi:10090">mice</span>
Requirement of IL-17RB+ NKT cells in the development of IL-25-induced AHR. (A) FACS profiles of NKT cells in the expression of IL-17RB. alpha-GalCer/CD1d dimerhi TCRbetahi NKT cells and alpha-GalCer/CD1d dimerint TCRbetaint NKT cells in the spleen from BALB/c mice were gated, and IL-17RB expression was analyzed using F(ab')2 IL-17RB mAb B5F6. IL-17RB was preferentially expressed in alpha-GalCer/CD1d dimerhi TCRbetahi NKT cells (n = 3). (B) FACS profiles of NKT cells in mice treated with IL-17RB mAb. alpha-GalCer/CD1d dimer+ TCRbeta+ NKT cells in the spleen from BALB/c mice at the indicated days after injection of 3H8 IL-17RB mAb or control rat IgG2a (1 mg/mouse) were gated and analyzed by FACS. Depletion of IL-17RB+ NKT cells persisted for at least 5 d after 3H8 injection because of the absence of alpha-GalCer/CD1d dimerhi TCRbetahi NKT cells in A (n = 2). Percentages are shown. (C) Development of AHR in mice treated with IL-17RB mAb. The detailed method for development of OVA/IL-25-induced AHR is described in Materials and methods. In brief, OVA/alum-sensitized mice were injected with 3H8 IL-17RB mAb or rat IgG2a (1 mg/mouse) 24 h before 2 mug IL-25 or PBS treatment and were challenged with OVA after 24 h, and RL was determined after 48 h. The group of rat IgG2a-treated WT mice was compared with three other groups. Results are expressed as means +/- SEM. The results represent one out of three experiments with five mice in each group. *, P < 0.05; and **, P < 0.01 calculated by ANOVA. (D) AHR development after cell transfer of spleen IL-17RB+ NKT cells into Jalpha18-/- mice. The detailed method for development of OVA/IL-25-induced AHR is described in Materials and methods. Indicated cell numbers of sorted IL-17RB+, IL-17RB- NKT, or total NKT cells from spleen or PBS control were intravenously transferred into OVA/alum-sensitized Jalpha18-/- mice 24 h before treatment with 3 mug IL-25 and were challenged with OVA after 24 h, and RL was measured after 48 h. Each group of IL-17RB+ NKT cell-transferred mice was compared with three other groups. *, P < 0.05; and **, P < 0.01 calculated by the Kruskal-Wallis test. The results represent one out of four experiments with five mice in each group. Results are expressed as means +/- SEM.
###end p 22
###begin p 23
###xml 36 37 36 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 145 146 145 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 170 173 166 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 236 244 232 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 275 276 271 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 303 304 299 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 393 394 389 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 575 576 571 572 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 650 658 646 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 697 698 693 694 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 710 718 706 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 799 800 795 796 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 824 832 820 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 857 858 853 854 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 174 178 <span type="species:ncbi:10090">mice</span>
To confirm the findings that IL-17RB+ NKT cells are essential for the development of IL-25-dependent AHR, we transferred enriched splenic IL-17RB+ NKT cells into Jalpha18-/- mice and tested their ability to develop IL-25-dependent AHR (Fig. 4 D). The cell transfer of IL-17RB+ NKT cells, but not IL-17RB- NKT cells nor PBS alone, restored AHR induced by OVA plus IL-25, indicating that IL-17RB+ NKT cells in the lung are functionally equivalent to those in the spleen. In addition, when equal numbers of cells were transferred, the severity of AHR induced by enriched IL-17RB+ NKT cells was almost three times higher than the total spleen NKT cells (Fig. 4 D), consistent with the ratio of IL-17RB+ NKT cells (Fig. 1 B). This indicates that the severity of AHR depends on the cell numbers of IL-17RB+ NKT cells transferred (Fig. 4 D) and, thus, that IL-17RB+ NKT cells contribute to the development of IL-25-dependent AHR.
###end p 23
###begin p 24
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 342 344 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 464 465 464 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 124 132 <span type="species:ncbi:9606">patients</span>
###xml 248 253 <span type="species:ncbi:9606">human</span>
###xml 408 413 <span type="species:ncbi:9606">human</span>
Although we have not identified the cells producing IL-25 in the present report, it is detected in lung biopsy samples from patients with asthma (29). In addition, IL-25 has been reported to induce inflammatory cytokine and chemokine production by human lung fibroblasts, and components of extracellular matrix by airway smooth muscle cells (29). These reports have also suggested that IL-25 plays a role in human asthma (29). Our findings clearly revealed IL-17RB+ NKT cells as target cells of IL-25 in the development of AHR or asthma. The efficacy with which IL-17RB antibodies prevent AHR and reduce Th2-cytokine-induced inflammation in vivo suggests that IL-17RB is an ideal therapeutic target for asthma.
###end p 24
###begin title 25
MATERIALS AND METHODS
###end title 25
###begin title 26
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice.
###end title 26
###begin p 27
###xml 143 145 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
###xml 194 198 <span type="species:ncbi:10090">Mice</span>
BALB/c mice were purchased from Charles River Laboratories or Clea Japan, Inc. Jalpha18-deficient mice were generated as previously described (30) and were backcrossed >10 times to BALB/c mice. Mice were kept under specific pathogen-free conditions and were used at 8-16 wk of age. All experiments were in accordance with protocols approved by the RIKEN Animal Care and Use Committee.
###end p 27
###begin title 28
###xml 14 19 <span type="species:ncbi:10090">mouse</span>
Generation of mouse IL-17RB-specific mAbs.
###end title 28
###begin p 29
###xml 89 94 <span type="species:ncbi:10090">mouse</span>
###xml 138 143 <span type="species:ncbi:9606">human</span>
###xml 360 365 <span type="species:ncbi:10090">Mouse</span>
###xml 414 418 <span type="species:ncbi:10116">rats</span>
The IL-17RB-Ig fusion gene was created by fusing the cDNA of the extracellular domain of mouse IL-17RB in frame to the CH2/CH3 domains of human IgG1 in the pIRES2-EGFP expression vector (Clontech Laboratories, Inc.). IL-17RB-Ig was purified from the culture supernatants of transfected HEK293 cells using a protein A-sepharose column (GE Healthcare; Fig. S2). Mouse IL-17RB mAbs were produced by immunizing Wister rats with IL-17RB-Ig. After initial screening by ELISA on IL-17RB-Ig fusion protein, 100 hybridoma clones were further characterized by flow cytometry on IL-17RB transfectants (Fig. S1).
###end p 29
###begin title 30
OVA/IL-25-induced AHR model.
###end title 30
###begin p 31
###xml 157 159 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 583 589 581 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 902 903 895 896 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 912 913 905 906 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1059 1067 1052 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 1094 1095 1087 1088 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1183 1191 1176 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 C</xref>
###xml 221 225 <span type="species:ncbi:10090">mice</span>
###xml 418 422 <span type="species:ncbi:10090">mice</span>
###xml 602 606 <span type="species:ncbi:10090">mice</span>
###xml 703 707 <span type="species:ncbi:10090">mice</span>
The original protocol for induction of AHR by OVA sensitization (100 mug three times) and challenge (100 mug OVA/alum three times), as previously described (16), was modified in the present study. In our modified method, mice were intraperitoneally immunized with a suboptimal dose of OVA/alum twice and were subsequently challenged once with intranasal OVA at the same time points as described. In this model, BALB/c mice failed to induce development of AHR, cell infiltration, and histological changes in the lung without IL-25 but induced AHR with intravenous injection of IL-25 (Fig. 3). In brief, mice were intraperitoneally immunized with 50 mug/2 mg OVA/alum twice at a 1-wk interval. 7 d later, mice were treated intravenously with 2 mug/200 mul IL-25 or 200 mul of control PBS at 2 d before intranasal challenge with 50 mug OVA. 24 h later, AHR responses were measured. For transfer of IL-17RB+, IL-17RB- NKT, or total NKT cells, cells were sorted by a FACSAria (BD). Sorted cells or PBS alone were intravenously injected 1 d before IL-25 treatment (Fig. 4 D). For depletion of IL-17RB+ cells, 1 mg 3H8 IL-17RB mAb was intraperitoneally injected 5 d before AHR measurement (Fig. 4 C).
###end p 31
###begin title 32
Measurement of airway responsiveness.
###end title 32
###begin p 33
###xml 62 63 62 63 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
Airway function was measured for changes in lung resistance (RL) and dynamic compliance in response to increasing doses of inhaled methacholine (1.25, 2.5, 5, 10, and 20 mg/ml) by using an invasive flexiVent (SCIREQ Scientific Respiratory Equipment Inc.).
###end p 33
###begin title 34
Lymphocyte isolation and analysis of BAL fluid.
###end title 34
###begin p 35
###xml 199 201 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 279 281 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
After measurement of AHR and death, the lung of the mouse trachea canulated was lavaged twice with 1 ml PBS (approximately10-fold PBS dilution), and the BAL fluid was pooled as previously described (13). Spleen, blood, and lung lymphocytes were isolated as described previously (31).
###end p 35
###begin title 36
Cytokine measurement.
###end title 36
###begin p 37
BAL fluid and culture supernatants were collected and analyzed by cytometric bead array (BD) according to the manufacturer's protocol.
###end p 37
###begin title 38
Flow cytometry.
###end title 38
###begin p 39
###xml 72 77 <span type="species:ncbi:10090">mouse</span>
###xml 119 124 <span type="species:ncbi:10090">mouse</span>
###xml 159 164 <span type="species:ncbi:10090">mouse</span>
###xml 196 201 <span type="species:ncbi:10090">mouse</span>
###xml 226 231 <span type="species:ncbi:10090">mouse</span>
###xml 262 267 <span type="species:ncbi:10090">mouse</span>
###xml 300 305 <span type="species:ncbi:10090">mouse</span>
Antibodies used for flow cytometric analysis were as follows: FITC anti-mouse TCRbeta (H57-597; BD), Pacific blue anti-mouse CD4 (RM4-5; BD), PerCP-Cy5.5 anti-mouse CD8alpha (53-6.7; BD), PE anti-mouse CD44 (IM7; BD), PE anti-mouse CD122 (TM-beta1; BD), PE anti-mouse CD62L (MEL-14; BD), and PE anti-mouse NKG2D (C7; eBioscience).
###end p 39
###begin title 40
Proliferation assay.
###end title 40
###begin p 41
###xml 144 145 144 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
Proliferation assays were done in 96-well U-bottomed plates. The spleen cell cultures were incubated for 3 d and pulsed with 0.037 MBq/well of [3H]thymidine (GE Healthcare) for the last 16 h. Radioactivity was measured using a MicroBeta (PerkinElmer).
###end p 41
###begin title 42
Quantitative real-time PCR.
###end title 42
###begin p 43
The PCR was performed with the Platinum SYBR Green qPCR SuperMix-UGD kit with ROX (Invitrogen) according to the protocol provided. A sequence detection system (ABI PRISM 7900HT; Applied Biosystems) was used for quantitative real-time PCR according to the manufacturer's instructions. To ensure the specificity of the amplification products, a melting curve analysis was performed. Results were normalized using the internal control gene HPRT. Sequences of PCR primers (Table S1) were designed with Primer Express software (Applied Biosystems) for optimal product length, germinal center content, and Tm value.
###end p 43
###begin title 44
Statistical analysis.
###end title 44
###begin p 45
The statistical significance of differences was determined by analysis of variance (ANOVA) or the Kruskal-Wallis test. The values were expressed as means +/- SEM from independent experiments. Any difference with a p-value of <0.05 was considered significant (*, P < 0.05; **, P < 0.01).
###end p 45
###begin title 46
Online supplemental material.
###end title 46
###begin p 47
###xml 252 253 252 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 311 312 311 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 385 386 385 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 400 401 392 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 414 415 406 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 28 33 <span type="species:ncbi:10090">mouse</span>
###xml 102 107 <span type="species:ncbi:10090">mouse</span>
###xml 185 190 <span type="species:ncbi:10090">mouse</span>
###xml 336 341 <span type="species:ncbi:10090">mouse</span>
###xml 430 434 <span type="species:ncbi:10090">mice</span>
Fig. S1 shows generation of mouse IL-17RB-specific mAbs. Fig. S2 shows expression and purification of mouse IL-17RB-Ig fusion protein. Fig. S3 shows FACS profiles of cells stained with mouse IL-17RB-specific mAbs. Fig. S4 shows RT-PCR analysis on c-kit+ NBNT cells and NKT cell subsets. Fig. S5 provides IL-17RB+ NKT cells in different mouse strains. Fig. S6 shows FACS analysis on CD4+ T, gammadelta+ T, and c-kit+ NBNT cells in mice treated with anti-IL-17RB mAb. Table S1 lists primers used for quantitative real-time PCR analysis. Online supplemental material is available at .
###end p 47
###begin title 48
Supplementary Material
###end title 48
###begin title 49
[Supplemental Material Index]
###end title 49
###begin p 50
We thank P.D. Burrows for critical reading; S. Seki, T. Aoyama, A. Hijikata, and H. Kitamura for technical assistance; T. Tashiro and K. Mori for alpha-GalCer synthesis; and N. Takeuchi for secretarial assistance.
###end p 50
###begin p 51
The authors have no conflicting financial interests.
###end p 51

